Skip to main content
STAA
NASDAQ Life Sciences

STAAR Surgical 预测 Q1 净销售额超过 9000 万美元

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
8
Price
$24.47
Mkt Cap
$1.034B
52W Low
$14.69
52W High
$30.81
Market data snapshot near publication time

summarizeSummary

STAAR Surgical 宣布初步第一季度净销售额预计超过 9000 万美元。这一积极的指导是在公司经历了具有挑战性的 2025 财年之后做出的，在那一年中，公司报告了净销售额大幅下降 23.7% 和净亏损扩大。预计的 Q1 业绩表明公司的运营轨迹可能正在稳定或开始早期转型，这可能是股价的一个重要积极催化剂。交易者将密切关注官方 Q1 盈利发布，以确认这些数字和任何更新的全年预测。

在该公告发布时，STAA的交易价格为$24.47，交易所为NASDAQ，所属行业为Life Sciences，市值约为$10.3亿。 52周交易区间为$14.69至$30.81。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed STAA - Latest Insights

STAA
Apr 08, 2026, 4:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
STAAR Surgical Forecasts Q1 Net Sales Above $90M
Sentiment: Positive
View Wiseek Article
STAA
Apr 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
STAAR Surgical Projects Q1 Net Sales Over $90M, Signaling Strong Rebound and Profit Improvement
Sentiment: Positive
View Wiseek Article
STAA
Mar 13, 2026, 9:29 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Broadwood Partners, Director Bradsher Confirm $12.2M Stake Increase; LeBuhn Exits Reporting Group
Sentiment: Positive
View Wiseek Article
STAA
Mar 13, 2026, 7:59 PM EDT
Filing Type: 4
Importance Score:
9
Major Insider Purchase: Broadwood Partners, a 10% Owner and Director, Buys $12.2M in STAAR Surgical Stock
Sentiment: Positive
View Wiseek Article
STAA
Mar 03, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
9
STAAR Surgical Reports 24% Revenue Drop, Posts $80.4M Net Loss in 2025 10-K
Sentiment: Negative
View Wiseek Article
STAA
Mar 03, 2026, 3:58 PM EST
Filing Type: 10-K
Importance Score:
9
STAAR Surgical Reports Steep Sales Decline, Widened Loss, Failed Merger, and CEO Exit in Challenging FY2025
Sentiment: Negative
View Wiseek Article
STAA
Feb 05, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7
STAAR Surgical's Chief Legal Officer Departs Amidst Ongoing Executive Restructuring
Sentiment: Negative
View Wiseek Article
STAA
Feb 02, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
STAAR Surgical Appoints President Foust and CFO Andrews as Interim Co-CEOs
Sentiment: Neutral
View Wiseek Article
STAA
Jan 16, 2026, 8:27 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Activist Broadwood Partners Secures Board Seats, CEO Departure at STAAR Surgical
Sentiment: Positive
View Wiseek Article
STAA
Jan 16, 2026, 8:03 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
STAAR Surgical Appoints Significant Shareholder Representative to Board
Sentiment: Positive
View Wiseek Article